Pharma pumps up lobbying spend

Roll Call finds some significant increases in lobbying spend between Q4 and Q1.

Anti IP reform documents published

PMLive has documents that outline a strategy to keep intellectual property laws from relaxing in South Africa.

PhRMA sets up shop in the UAE

The group's offices will be in the DuBiotech research cluster.

Business briefs: inVentiv, Novo, Bayer, Purdue

inVentiv launches new policy shop; early test shows Novo's Victoza may have Alzheimer's future; Bayer joins the list of China's scrutinized pharma companies; a Chicago bar gives Purdue unwanted attention

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.